Found 5 matching trials
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor Therapy PHASE2 The purpose of this study is to determine if bempedoic acid (ETC-1002) 180m...
Show More Location
L-MARC Research Center
Learn More & Join Trial
A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia PHASE2 The purpose of this study is to assess the low-density lipoprotein choleste...
Show More Location
Tokyo-Eki Center-Building Clinic
Learn More & Join Trial
A Confirmatory Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia PHASE3 The purpose of this study is to confirm the superiority of ETC-1002 after 1...
Show More Location
Rinku General Medical Center
Learn More & Join Trial
A Long-term Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia PHASE3 A Multicenter, Open-label Study to assess the safety and efficacy of ETC-10...
Show More Location
Rinku General Medical Center
Learn More & Join Trial
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C PHASE2 The purpose of this study is to determine if triplet therapy with bempedoic...
Show More Location
PMG Research of Christie Clinic
Learn More & Join Trial